As federal scrutiny lands on Massachusetts colleges, Boston City Council debates whether the city should guarantee trans healthcare access. The outcome could reshape what LGBTQ residents can actually afford.
News
As federal scrutiny lands on Massachusetts colleges, Boston City Council debates whether the city should guarantee trans healthcare access. The outcome could reshape what LGBTQ residents can actually afford.
City Councilor Kendra Lara brought a stack of medical bills to a hearing last month, each one stamped with denials from insurance companies. The bills belonged to trans patients at a community health clinic in Jamaica Plain—people who had been told their hormone therapy, mental health care, and gender-affirming procedures weren't covered. Lara, who represents District 4, placed them on the table in front of her colleagues and didn't mince words: Boston was failing its trans residents, and the city had a legal obligation to fix it.
The moment felt urgent because it was. Across Massachusetts, the Department of Education has begun investigating Smith College's trans-inclusive admissions and support policies, a federal probe that signals Washington is willing to scrutinize how institutions handle transgender students. Meanwhile, Boston's trans community—already navigating a healthcare system that treats gender-affirming care like an optional luxury—watches the clock tick on whether the city will act before those federal winds shift further.
Lara's proposal is straightforward in theory, complicated in practice: require the city to ensure that all Boston residents have access to trans healthcare, regardless of insurance status or ability to pay. The ordinance would make Boston one of the first major cities to explicitly guarantee such access through municipal policy. It would also cost money the city says it doesn't have, which is why the debate has stalled in committee for months.
The healthcare desert is real. Trans residents report waiting months for appointments at Fenway Health, the only major provider in Boston offering comprehensive trans care. Those without insurance or with plans that exclude gender-affirming services face the choice between paying out-of-pocket—hormone therapy can run three hundred dollars a month without coverage—or going without. Some patients have described rationing doses or skipping appointments entirely. Others have traveled to Providence or New York for care their own city wouldn't fund.
The city's budget office has pushed back against Lara's proposal, arguing that the city cannot unilaterally guarantee healthcare that insurance companies deny. But Lara and her allies counter that the city already subsidizes healthcare for uninsured residents through its health centers. Why, they ask, should trans care be different? Why should the city treat hormone therapy as less essential than diabetes medication?
This isn't abstract policy debate. It's personal. At a community meeting in Roxbury last fall, a trans woman named Maya described injecting hormones that she'd bought online because she couldn't afford a doctor visit or a prescription. She'd never met with an endocrinologist. She didn't know if her dosage was safe. She'd chosen between rent and healthcare, and rent had won. When Lara asked her whether a city-guaranteed program would change her situation, Maya's eyes filled with tears. She said yes.
Boston's trans population skews young and economically precarious. Many work in service jobs with no benefits. Others are students. Some are unhoused or housing-insecure. The median income for trans households in Massachusetts is substantially lower than the state average. When the city talks about "access," it's often talking about people who already have some pathway to care. For Boston's most marginalized trans residents, access doesn't exist.
The ordinance has support from Councilors Michelle Wu, Anissa Essaibi George, and others, but it's stalled in the health and human services committee, where Chair Lydia Edwards has expressed concern about cost and implementation. Edwards hasn't blocked the ordinance outright, but she's asked for a more detailed fiscal analysis—a request that, in municipal politics, often means indefinite study.
Meanwhile, the federal investigation into Smith College's policies has created an opening for anti-trans rhetoric in Massachusetts. State officials have been careful not to take explicit sides, but the message is clear: institutions that prioritize trans inclusion are now under federal scrutiny. That chilling effect has already rippled through Boston's education sector, where some administrators have quietly scaled back trans support programs.
For the trans patients waiting for care, the political theater feels distant. One trans man, Derek, described calling ten endocrinologists in Boston before finding one who would see him. That doctor told him there was a six-month wait. Derek couldn't wait six months. He found a provider in Cambridge instead, a thirty-minute commute that meant taking time off work. He still doesn't have insurance coverage for his care. The city's ordinance would change that. Or it wouldn't. The committee will decide.
Lara has signaled she's willing to compromise—perhaps the city could guarantee access through partnerships with existing providers rather than building new infrastructure. Perhaps the guarantee could be phased in. The council has time, technically. But trans healthcare doesn't wait. Bodies don't wait. The gap between what Boston claims to value and what it actually funds for its trans residents grows wider each month the ordinance sits in committee.
The next hearing is scheduled for late spring. By then, some patients will have found workarounds. Others will have given up. A few might have moved away, deciding that a city that can't guarantee basic healthcare isn't worth staying in. Boston likes to call itself progressive. The ordinance would test whether that means anything when the bill comes due.